Drug Executive Collapses During Oval Office Press Conference
A press conference in the Oval Office was abruptly interrupted when a drug executive fainted while President Donald Trump announced a pricing deal with pharmaceutical companies.
Incident Details
During the Thursday event, President Trump and representatives from Eli Lilly and Novo Nordisk discussed a new agreement to expand coverage and reduce prices for popular obesity medications, Zepbound and Wegovy.
David Ricks, CEO of Eli Lilly, was speaking when he noticed Gordon Findlay, Novo Nordisk’s global brand director, suddenly collapse.
"Are you okay? Gordon, are you okay?" – David Ricks
Immediate Response
Dr. Mehmet Oz, the Administrator for the Centers for Medicare & Medicaid Services, quickly assisted as Findlay fell to his knees and lost consciousness.
The press was promptly asked to leave the room following the incident. Health and Human Services Secretary was present during the event.
Aftermath
About 30 minutes later, the press conference resumed with President Trump providing an update on Findlay’s condition.
"President Donald Trump looks on as Dr. Mehmet Oz and others help Gordon Findlay."
Summary
The sudden collapse of a key drug executive during a high-profile price reduction announcement highlights the unexpected nature of live political events and the quick response by medical professionals present.